MENU
SOLV
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

SOLV stock forecast, quote, news & analysis

Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs... Show more

SOLV
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for SOLV with price predictions
Jul 31, 2026

SOLV's RSI Oscillator leaves overbought zone

The 10-day RSI Indicator for SOLV moved out of overbought territory on July 30, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 instances where the indicator moved out of the overbought zone. In of the 16 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOLV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SOLV broke above its upper Bollinger Band on July 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 15, 2026. You may want to consider a long position or call options on SOLV as a result. In of 40 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SOLV just turned positive on July 27, 2026. Looking at past instances where SOLV's MACD turned positive, the stock continued to rise in of 21 cases over the following month. The odds of a continued upward trend are .

SOLV moved above its 50-day moving average on July 24, 2026 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for SOLV moved above the 200-day moving average on July 01, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where SOLV advanced for three days, in of 133 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 83 cases where SOLV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SOLV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.977) is normal, around the industry mean (5.137). P/E Ratio (10.458) is within average values for comparable stocks, (202.232). Projected Growth (PEG Ratio) (1.220) is also within normal values, averaging (3.455). Dividend Yield (0.000) settles around the average of (0.021) among similar stocks. P/S Ratio (1.815) is also within normal values, averaging (84.005).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOLV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 8.1B. The market cap for tickers in the group ranges from 126 to 124.82B. ISRG holds the highest valuation in this group at 124.82B. The lowest valued company is HGYMF at 126.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 5%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was -2%. SMTI experienced the highest price growth at 32%, while FEMY experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 17%. For the same stocks of the Industry, the average monthly volume growth was -6% and the average quarterly volume growth was -13%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 62
Price Growth Rating: 53
SMR Rating: 84
Profit Risk Rating: 96
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
SOLV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Details
Industry
N/A
Address
3M Center
Phone
+1 651 733-1110
Employees
N/A
Web
https://www.3m.com
SOLV's RSI Oscillator leaves overbought zone